Reviva Pharmaceuticals Holdings, Inc.
RVPH· OTC
RVPHReviva Pharmaceuticals Holdings, Inc.
Filed May 13, 2026 · 10-Q · 43 days after period end · 0001437749-26-016762
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Net Income | -$3.20M | -$6.43M | -$7.43M | -$6.60M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Reviva Pharmaceuticals Holdings, Inc. · CIK 1742927 · Engraved from SEC EDGAR
ended Mar 31, 2026 · filed May 13, 2026 · 43 d after period end
